The European Conference on AI for Clinical Applications (Euraica2026) which will take place in Brussels, Belgium on 11 – 12 March, 2026.
This conference will explore how Artificial Intelligence (AI) is transforming the landscape of clinical research. From early protocol design to post-trial evidence generation, AI technologies are accelerating timelines, enhancing decision-making, and improving trial efficiency. By leveraging real-world data (RWD), predictive models, and automation tools, AI is driving a more adaptive, patient-centered, and evidence-driven R&D process. At the same time, these innovations raise new methodological, regulatory, and ethical questions that deserve collective attention.
This event is a unique opportunity to engage with academic researchers, regulatory authorities, HTA representatives, investors, entrepreneurs, and executive leaders from pharmaceutical and biotech companies involved in clinical development, medical affairs, and regulatory strategy.
